Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00011193 · ClinicalTrials.gov registry record
Dose-Response to Exercise in Women Aged 45-75 Years (DREW)
A clinical trial, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- 464
- Enrollment target
NCT00011193: Completed study, sponsored by Pennington Biomedical Research Center.
NCT00011193 is a clinical trial that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 464 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00011193 has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- 464 participants
- Enrollment target
Study Summary
To investigate the effects of different amounts of exercise on both cardiorespiratory fitness and risk factors for cardiovascular disease in sedentary, overweight, mildly hypertensive, but healthy, postmenopausal women aged 45 to 75 years.
Interventions
- BEHAVIORAL Exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 464 participants |
| Start Date | 2001-01 |
| Est. Completion | 2006-12 |
What the finished NCT00011193 record still lists
NCT00011193 is an observational study that tracks outcomes without assigning an intervention. The registered 464 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Exercise is the first listed.
NCT00011193 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00011193 about?
NCT00011193 is a clinical study titled "Dose-Response to Exercise in Women Aged 45-75 Years (DREW)". To investigate the effects of different amounts of exercise on both cardiorespiratory fitness and risk factors for cardiovascular disease in sedentary, overweight, mildly hypertensive, but healthy, postmenopausal women aged 45 to 75 years.
What is the current status of trial NCT00011193?
This trial is currently completed. The enrollment target is 464 participants. The study started on 2001-01. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00011193?
The interventions under investigation include: Exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT00011193?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04787744 · 464 participants · Phase 2
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
- NCT04855656 · 464 participants · Phase 1
Study of Lunresertib Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid Tumors
- NCT06283927 · 464 participants
The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
- NCT06444295 · 464 participants · NA
Testing the Impact of Thrive App Versions on Alcohol Use and Posttraumatic Stress After Recent Sexual Assault
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia